29 SME IPOs Deliver Multibagger Returns Despite Challenging Market Conditions in 2025
Despite challenging conditions in 2025, 29 SME stocks delivered multibagger returns exceeding 100% from IPO prices, led by Anondita Medicare's 500%+ gains. While over 250 SME IPOs raised nearly ₹11,000 crore, average listing gains fell to 12.60%—the weakest since 2020. Successful companies operated in niche sectors like healthcare and manufacturing, demonstrating that quality fundamentals continued to drive performance even amid broader market struggles.

*this image is generated using AI for illustrative purposes only.
India's SME IPO market experienced a sharp reality check in 2025, with the segment facing significant headwinds despite record fundraising levels. However, a select group of 29 SME stocks managed to deliver exceptional multibagger returns, proving that quality fundamentals can drive performance even during challenging market conditions.
Market Performance Overview
According to data from Trendlyne, approximately 29 SME stocks delivered gains exceeding 100% from their IPO prices, standing out in a year when the broader SME universe struggled significantly. This performance becomes more remarkable considering the overall market sentiment and reduced enthusiasm for SME IPOs throughout 2025.
| Market Metric | 2025 Performance | Context |
|---|---|---|
| Total SME IPOs | Over 250 | Highest count |
| Total Fundraising | Nearly ₹11,000 crore | Highest annual amount |
| Average Listing Gains | 12.60% | Weakest since 2020 |
| Flat/Negative Debut Returns | ~120 IPOs | vs. 33 in 2024 |
| Trading Below Issue Price | ~130 IPOs | Significant underperformance |
This marked a dramatic shift from the previous period between 2022 and 2024, when average SME IPO listing gains surged from roughly 33% to almost 60%, fueled by abundant liquidity, aggressive retail participation, and minimal price discipline.
Top Performing Stocks
Among the standout performers, several companies delivered exceptional returns ranging from 250% to over 500% from their IPO prices. Anondita Medicare led the pack with particularly impressive performance, listing at ₹145—a steep 90% premium over the issue price—and subsequently climbing to over ₹900, translating into gains exceeding 500%.
| Top Performers | Return Range | Sector Focus |
|---|---|---|
| Anondita Medicare | Over 500% | Healthcare |
| Tankup Engineers | Over 300% | Engineering Solutions |
| Fabtech Technologies Cleanrooms | Over 300% | Cleanroom Infrastructure |
| Cryogenic OGS | 250%+ | Industrial Services |
| Monolithisch India | 250%+ | Manufacturing |
Financial Performance Highlights
Anondita Medicare's strong post-listing performance was supported by robust financial growth over the past two years. The company demonstrated exceptional operational improvements across key metrics.
| Financial Metric | FY25 | FY24 | Growth |
|---|---|---|---|
| Revenue | ₹77.13 crore | ₹46.56 crore | 66% |
| Profit After Tax | ₹16.42 crore | ₹3.84 crore | 327% |
Similarly, other multibagger performers like Tankup Engineers and Fabtech Technologies Cleanrooms delivered gains exceeding 300%, defying the broader SME market slowdown through strong fundamentals and sector positioning.
Market Differentiation Factors
Analysts noted that successful companies distinguished themselves through several key characteristics rather than market hype. Many multibagger performers operated in niche sectors including manufacturing, industrial services, healthcare, engineering solutions, and cleanroom infrastructure—segments where order books, client relationships, and execution capabilities proved more important than sentiment-driven trading.
Additionally, several successful IPOs demonstrated strong subscription levels, often running into hundreds or thousands of times oversubscription, particularly in HNI and retail categories. While high subscription alone did not guarantee success in 2025, it helped signal areas of strong investor conviction.
Market Evolution and Outlook
The SME platform was originally designed to address structural gaps in Indian capital markets, providing funding access to small and medium enterprises that historically relied on bank loans or private funding. However, speculative excess gradually emerged, leading to regulatory intervention by SEBI in late 2024 and 2025.
"Investors need to select companies meticulously, with thorough fundamental analysis. Businesses with sound models, strong profitability, favorable industry prospects and reasonable valuations can still deliver long-term multibagger returns," said Sunil Nyati, MD at Swastika Investmart.
The fact that only a subset of stocks delivered multibagger returns in 2025 may signal market maturation, with improved quality standards and investor scrutiny becoming more prominent factors in performance outcomes.






























